The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 11, 2019

Filed:

Apr. 27, 2015
Applicant:

Pierre Fabre Medicament, Boulogne-Billancourt, FR;

Inventors:

Ian Rilatt, Castres, FR;

Michel Perez, Castres, FR;

Liliane Goetsch, Ayze, FR;

Matthieu Broussas, Seyssel, FR;

Charlotte Beau-Larvor, Jonzier Epagny, FR;

Jean-Francois Haeuw, Beaumont, FR;

Marie Lamothe, Montredon Labessonnie, FR;

Assignee:

PIERRE FABRE MEDICAMENT, Boulogne-Billancourt, FR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 47/48 (2006.01); A61K 39/395 (2006.01); A61K 47/68 (2017.01);
U.S. Cl.
CPC ...
A61K 47/6803 (2017.08); A61K 47/6855 (2017.08); A61K 47/6857 (2017.08); A61K 47/6859 (2017.08); A61K 47/6863 (2017.08); A61K 47/6865 (2017.08); A61K 47/6867 (2017.08); A61K 47/6869 (2017.08);
Abstract

The present invention relates to an antibody-drug-conjugate. From one aspect, the invention relates to an antibody-drug-conjugate comprising an antibody capable of binding to a Target, said antibody being conjugated to at least one drug selected from derivatives of dolastatin 10 and auristatins. The invention also comprises method of treatment and the use of said antibody-drug-conjugate for the treatment of cancer.


Find Patent Forward Citations

Loading…